Importer of Controlled Substances; Notice of Registration; GE Healthcare, 14296 [2014-05480]
Download as PDF
<![CDATA[
14296
Federal Register / Vol. 79, No. 49 / Thursday, March 13, 2014 / Notices
DEPARTMENT OF JUSTICE
DEPARTMENT OF JUSTICE
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Drug Enforcement Administration
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration; GE Healthcare
Importer of Controlled Substances;
Notice of Registration; Siegfried USA,
LLC
Importer of Controlled Substances;
Notice of Registration; Johnson
Matthey, Inc.
By Notice dated December 23, 2013,
and published in the Federal Register
on January 10, 2014, 79 FR 1887,
Siegfried USA, LLC., 33 Industrial Park
Road, Pennsville, New Jersey 08070,
made application by renewal to the
Drug Enforcement Administration
(DEA) to be registered as an importer of
the following basic classes of controlled
substances:
By Notice dated November 4, 2013,
and published in the Federal Register
on November 18, 2013, 78 FR 69130,
Johnson Matthey, Inc., Pharmaceutical
Materials, 2003 Nolte Drive, West
Deptford, New Jersey 08066–1742, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as an importer of the
following basic classes of controlled
substances:
By Notice dated November 2, 2013,
and published in the Federal Register
on November 19, 2013, 78 FR 69447, GE
Healthcare, 3350 North Ridge Avenue,
Arlington Heights, Illinois 60004–1412,
made application by renewal to the
Drug Enforcement Administration
(DEA) to be registered as an importer of
Cocaine (9041), a basic class of
controlled substance listed in schedule
II.
The company plans to import small
quantities of ioflupane, in the form of
three separate analogues of Cocaine, that
will be used for the support and
manufacture of DaTSCAN (ioflupane I–
123) injections for distribution as a
radioactive diagnostic imaging agent
utilized in the diagnosis of Parkinson’s
disease.
No comments or objections have been
received. The DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a),
and determined that the registration of
GE Healthcare to import the basic class
of controlled substance is consistent
with the public interest, and with
United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971. The
DEA has investigated GE Healthcare to
ensure that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic class of controlled substance
listed.
TKELLEY on DSK3SPTVN1PROD with NOTICES
Dated: February 19, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2014–05480 Filed 3–12–14; 8:45 am]
BILLING CODE 4410–09–P
Drug
Schedule
Opium, raw (9600) .......................
Poppy Straw Concentrate (9670)
II
II
The company plans to import the
listed controlled substances to bulk
manufacture APIs for distribution to its
customer.
Comments and requests for hearings
on applications to import narcotic raw
material are not appropriate. 72 FR 3417
(January 25, 2007).
The DEA has considered the factors in
21 U.S.C. 823(a) and 952(a), and
determined that the registration of
Siegfried USA, LLC., to import the basic
classes of controlled substances is
consistent with the public interest, and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971. The
DEA has investigated Siegfried USA,
LLC., to ensure that the company’s
registration is consistent with the public
interest. The investigation has included
inspection and testing of the company’s
physical security systems, verification
of the company’s compliance with state
and local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the above named
company is granted registration as an
importer of the basic classes of
controlled substances listed.
Dated: February 19, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2014–05497 Filed 3–12–14; 8:45 am]
BILLING CODE 4410–09–P
VerDate Mar<15>2010
17:33 Mar 12, 2014
Jkt 232001
PO 00000
Frm 00085
Fmt 4703
Sfmt 4703
Drug
Coca Leaves (9040) .....................
Thebaine (9333) ...........................
Opium, raw (9600) .......................
Noroxymorphone (9668) ..............
Poppy Straw Concentrate (9670)
Schedule
II
II
II
II
II
The company plans to import the
listed controlled substances as raw
materials, to be used in the manufacture
of bulk controlled substances, for
distribution to its customers.
Comments and requests for hearings
on applications to import narcotic raw
material are not appropriate. 72 FR
3417, (January 25, 2007).
In reference to the non-narcotic raw
material, no comments or objections
have been received. The company plans
to import gram amounts to be used as
reference standards for distribution to
its customers.
The DEA has considered the factors in
21 U.S.C. 823(a) and 952(a) and
determined that the registration of
Johnson Matthey, Inc. to import the
basic classes of controlled substances is
consistent with the public interest and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971. The
DEA has investigated Johnson Matthey,
Inc. to ensure that the company’s
registration is consistent with the public
interest. The investigation has included
inspection and testing of the company’s
physical security systems, verification
of the company’s compliance with state
and local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic classes of controlled
substances listed.
E:\FR\FM\13MRN1.SGM
13MRN1
]]>Agencies
[Federal Register Volume 79, Number 49 (Thursday, March 13, 2014)]
[Notices]
[Page 14296]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-05480]
[[Page 14296]]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Registration; GE
Healthcare
By Notice dated November 2, 2013, and published in the Federal
Register on November 19, 2013, 78 FR 69447, GE Healthcare, 3350 North
Ridge Avenue, Arlington Heights, Illinois 60004-1412, made application
by renewal to the Drug Enforcement Administration (DEA) to be
registered as an importer of Cocaine (9041), a basic class of
controlled substance listed in schedule II.
The company plans to import small quantities of ioflupane, in the
form of three separate analogues of Cocaine, that will be used for the
support and manufacture of DaTSCAN (ioflupane I-123) injections for
distribution as a radioactive diagnostic imaging agent utilized in the
diagnosis of Parkinson's disease.
No comments or objections have been received. The DEA has
considered the factors in 21 U.S.C. 823(a) and 952(a), and determined
that the registration of GE Healthcare to import the basic class of
controlled substance is consistent with the public interest, and with
United States obligations under international treaties, conventions, or
protocols in effect on May 1, 1971. The DEA has investigated GE
Healthcare to ensure that the company's registration is consistent with
the public interest. The investigation has included inspection and
testing of the company's physical security systems, verification of the
company's compliance with state and local laws, and a review of the
company's background and history. Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above
named company is granted registration as an importer of the basic class
of controlled substance listed.
Dated: February 19, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2014-05480 Filed 3-12-14; 8:45 am]
BILLING CODE 4410-09-P
